|
Volumn 21, Issue 4, 2001, Pages 280-288
|
Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study
|
Author keywords
Blood pressure; Clinical trial; Hemodialysis; Hypertension; Ultrafiltration rate
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
MERCURY;
ANTIHYPERTENSIVE ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIASTOLIC BLOOD PRESSURE;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
HEART ARRHYTHMIA;
HEMATOCRIT;
HEMODIALYSIS;
HUMAN;
HYPERTENSION;
INFORMATION PROCESSING;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NONLINEAR SYSTEM;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SYSTOLIC BLOOD PRESSURE;
ULTRAFILTRATION;
WEIGHT GAIN;
CLINICAL TRIALS;
CROSS-SECTIONAL STUDIES;
FEMALE;
HUMANS;
HYPERTENSION;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
MULTICENTER STUDIES;
RENAL DIALYSIS;
RISK FACTORS;
|
EID: 0034880014
PISSN: 02508095
EISSN: None
Source Type: Journal
DOI: 10.1159/000046262 Document Type: Article |
Times cited : (110)
|
References (38)
|